31 results
8-K
EX-99.1
ARVN
Arvinas Inc
6 Dec 23
Regulation FD Disclosure
7:01am
and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging … as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities
S-3ASR
EX-1.2
ARVN
Arvinas Inc
7 Nov 23
Automatic shelf registration
5:24pm
the Company or any of its properties (collectively, “Health Care Laws”), and has not engaged in any activities which are, as applicable, cause for false claims … subsidiaries under any Health Care Laws, except as would not, individually or in the aggregate, reasonably be expected to result in a Material Adverse
8-K
EX-99.1
w8j8rvshspb5h3
10 Dec 21
Regulation FD Disclosure
8:16am
8-K
EX-1.1
4rx 3wnmuciidfcj
6 Aug 21
Entry into a Material Definitive Agreement
4:09pm
8-K
EX-99.1
ahj1nfywxv05pq1 ktos
22 Jul 21
Arvinas and Pfizer Announce Global Collaboration to Develop and Commercialize PROTAC® Protein
7:30am
8-K
EX-10.1
v8g3tzmup4
22 Jul 21
Arvinas and Pfizer Announce Global Collaboration to Develop and Commercialize PROTAC® Protein
7:30am
8-K
EX-1.1
tpl u4uso
18 Dec 20
Arvinas, Inc. Announces Pricing of $400 Million Public Offering of Common Stock
6:30am
8-K
EX-1.1
kokcczm cjw
12 Nov 19
Arvinas, Inc. Announces Pricing of Public Offering of Common Stock
4:02pm